Moreton, P. et al. (2005) Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. Journal of Clinical Oncology, 23(13), pp. 2971-2979.
Full text not currently available from Enlighten.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Leach, Dr Michael |
| Authors: | Moreton, P., Kennedy, B., Lucas, G., Leach, M., Rassam, S., Haynes, A., Tighe, L., Oscier, D., Fegan, C., Rawstron, A., and Hillmen, P. |
| College/School: | College of Medical Veterinary and Life Sciences |
| Journal Name: | Journal of Clinical Oncology |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details